Joined June 2019
- Tweets 155
- Following 226
- Followers 221
- Likes 1,048
6 Photos and videos
Emmanuelle Vidal-Petiot retweeted
25 Feb 2025
86% of subjects are not abnormal !
New Definition of Elevated Blood Pressure in the 2024 ESC Guidelines: Increased Prevalence, Uncertain Evidence
our piece published today in Circulation ahajournals.org/doi/full/10.… #hypertension #prevention @EmmaVP5
14
32
4,129
Emmanuelle Vidal-Petiot retweeted
🚨 #JobAlert
Assistant spécialiste aux Explorations Fonctionnelles Rénales @hopitalbichat dès novembre 2024
👉 DFG, exploration des troubles phosphocalciques, hydro-électrolytiques...
👉 HTA (IIR et résistante, centre d'Excellence Européen)
👉 Infos et contact: DM @EmmaVP5
4
4
574
Emmanuelle Vidal-Petiot retweeted
17 Jun 2024
This Core Curriculum by Susan L. Murray and Myles Wolf reviews the physiology and pathophysiology of calcium and phosphate disorders through a series of cases, including clinical conundrums commonly encountered by nephrologists:
buff.ly/3Ns2PIG (FREE)
@DukeKidney
69
194
17,624
Emmanuelle Vidal-Petiot retweeted
5 Feb 2024
Hypertension is an risk factor for coronary events, stroke, heart failure, and ESKD. This study found the effects of intensive systolic BP lowering on cardiovascular end points and mortality in SPRINT were independent of time-varying diuretics use bit.ly/CJASN0406
ALT Visual Abstract for the article titled "Role of Diuretics in Cardiovascular Events and Mortality in Systolic Blood Pressure Intervention Trial"
1
24
54
5,890
Emmanuelle Vidal-Petiot retweeted
22 Nov 2023
Testing for 385 genes among 1623 CKD patients identified variants in 20.8%, half of whom had new or changed diagnosis, 90.7% change in management, and 32.9% change in treatment bit.ly/JASN0249
@ndahl48 @HilaMilo @fouadchebib @MayoClinicNeph @ColumbiaKidney
ALT Visual Abstract for the article titled "The Clinical Utility of Genetic Testing in the Diagnosis and Management of Adults with Chronic Kidney Disease"
13
26
5,633
Emmanuelle Vidal-Petiot retweeted
13 Nov 2023
SPRINT trial is now validated by ESPRIT RCT from China in high risk HTN including DM pts. Lowering SBP <120 compared with <140 reduces MACE by 12% , CVD death by 39%, all cause death by 21% #AHA23 🎉
2
14
39
4,804
Emmanuelle Vidal-Petiot retweeted
Dietary potassium stimulates Ppp1Ca-Ppp1r1a dephosphorylation of kidney NaCl cotransporter and reduces blood pressure: buff.ly/40nDkxi
@PAWellingMD @HopkinsMedicine
#Nephrology
1
17
45
12,642
Emmanuelle Vidal-Petiot retweeted
28 Sep 2023
Unilaterally Selective Adrenal Vein Sampling for Identification of Surgically Curable Primary Aldosteronism @DrJunYang @AmarLaurence @WuCent
ahajrnls.org/3EYPqmV
1
6
12
2,206
Emmanuelle Vidal-Petiot retweeted
20 Sep 2023
New review🫶🙌 with @EdinburghBean Salt Sensitivity: Causes, Consequences, and Recent Advances | Hypertension ahajournals.org/doi/abs/10.1…
6
30
4,031
Emmanuelle Vidal-Petiot retweeted
17 Sep 2023
New somatic mutation in Primary Aldosteronism. Zinc transporter 1 (ZnT1) gene SLC30A1. Congratulations @adina_turcu and group.
nature.com/articles/s41588-0…
5
21
2,338
Emmanuelle Vidal-Petiot retweeted
12 Sep 2023
Global Effect of Modifiable Risk Factors on Cardiovascular Disease and Mortality
@NEJM
nejm.org/doi/10.1056/NEJMoa2…
1
22
55
6,062
Emmanuelle Vidal-Petiot retweeted
11 Sep 2023
Happy to share this review just published in @ajprenal that covers the history of NCC and the development of knowledge along the years. doi.org/10.1152/ajprenal.001…
3
12
59
6,559
Emmanuelle Vidal-Petiot retweeted
10 Sep 2023
Editorial: A New Dawn for Aldosterone as a Therapeutic Target in Hypertension ja.ma/3Pe3LQS #Hypertension23
7
19
7,575
Emmanuelle Vidal-Petiot retweeted
6 Sep 2023
Happy to share that our paper led by talented IM chief resident @KyleOMalleyMD "Diagnostic performance of the adrenal vein to IVC aldosterone ratio in classifying the subtype of PA" is published in Hypertension Research. @UTSWIMchief @Kazuomi_Kario great journal IF >5 and no OA
2
9
30
2,346
Emmanuelle Vidal-Petiot retweeted
Attending the excellent Aldosterone session at #Hypertension23?
Check out this State-Of-the-Art review from @AnandVaidya17 and colleagues
academic.oup.com/ajh/article…
17
33
5,857
Emmanuelle Vidal-Petiot retweeted
1 Sep 2023
New and old GFR equations: a European perspective academic.oup.com/ckj/article…
A little story of estimating GFR...free access
5
21
1,374
Emmanuelle Vidal-Petiot retweeted
31 Aug 2023
New Research: Renal K retention in physiological circumstances: focus on adaptation of the distal nephron and cross-talk with Na transport systems #Physiology frontiersin.org/articles/10.…
2
6
2,184
Emmanuelle Vidal-Petiot retweeted
30 Aug 2023
Very interesting review in Pharmacology and Therapeutics by Kettritz and Loffing: "Potassium homeostasis–Physiology and Pharmacology in a clinical context."
doi.org/10.1016/j.pharmthera…
4
15
798
Emmanuelle Vidal-Petiot retweeted
25 Aug 2023
Des posts qui vous réconcilient avec Twitter/X
25 Aug 2023
[🔴 Thread pro de santé grand public 🔴]
Débat récurent: le casque est-il utile ou non à vélo ? 🚴♂️🪖
A thread ⬇️🧵
(merci de like ❤️ RT 🔁si le thread vous semble utile / intéressant)
#velo #velos #velotaff #velotaf #cyclisme #casque
1
3
738
Emmanuelle Vidal-Petiot retweeted
9 Aug 2023
And in this issue, our proof of concept for a personalized eGFR method, based on creatinine and muscle mass assessed by CT scan. More precise than the usual equations in case of sarcopenia or high muscle mass, and efficient regardless of ethnicity.
academic.oup.com/ckj/article…
8 Aug 2023
📢Check out the new August issue of CKJ!
Fully #openaccess:
📖academic.oup.com/ckj/issue/1…
🧐Editor's pick:
Sodium bicarbonate in kidney transplant recipients: do some apples a day keep the doctor away?
👉doi.org/10.1093/ckj/sfad117
1
7
18
2,517